Overview Miglustat in Cystic Fibrosis Status: Completed Trial end date: 2008-12-01 Target enrollment: Participant gender: Summary Single Center, Double-Blind, Randomized, Placebo-Controlled, Two-Period/Two-Treatment Crossover Study Investigating the Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation Phase: Phase 2 Details Lead Sponsor: ActelionTreatments: 1-DeoxynojirimycinMiglustat